Neumora Therapeutics, Inc. (NMRA)

NASDAQ: NMRA · IEX Real-Time Price · USD

12.08

+0.17 (1.43%)

Nov 28, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	31.12	24.55
Research & Development	91.75	55.78
Other Operating Expenses	13	157
Operating Expenses	135.87	237.32
Operating Income	-135.87	-237.32
Other Expense / Income	-4.97	-0.01
Pretax Income	-130.9	-237.31
Net Income	-130.9	-237.31
Shares Outstanding (Basic)	213	172
Shares Outstanding (Diluted)	213	172
Shares Change	24.25%	-
EPS (Basic)	-0.61	-1.38
EPS (Diluted)	-0.61	-1.38
Free Cash Flow	-115.41	-76.24
Free Cash Flow Per Share	-0.54	-0.44
EBITDA	-128.21	-235.76
Depreciation & Amortization	2.7	1.55
EBIT	-130.9	-237.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).